Search - Chimie ParisTech Access content directly

Filter your results

3 Results
Structure: Internal structure identifier : 95536

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

Benedicte Caron , Laurent Peyrin-Biroulet , Benjamin Pariente , Yoram Bouhnik , Philippe Seksik , et al.
Journal of Crohn's and Colitis, 2019, 13 (10), pp.1239-1247. ⟨10.1093/ecco-jcc/jjz088⟩
Journal articles hal-02363537v1

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

A. Amiot , M. Serrero , L. Peyrin-Biroulet , J. Filippi , B. Pariente , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (3), pp.310-321. ⟨10.1111/apt.14167⟩
Journal articles hal-01639670v1

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

C. Corpechot , O. Chazouilleres , A. Rousseau , D. Guyader , F. Habersetzer , et al.
Journal of Hepatology, 2017, 66 (1, S), pp.S89. ⟨10.1016/S0168-8278(17)30442-7⟩
Journal articles hal-03590930v1